Responding to continued growth in clinical trials as well as the increasing linkages across life sciences, diagnostics and healthcare, Oracle recently announced the formation of a new Global Business Unit focused on software applications for the health sciences industry. Neil de Crescenzo has been named Senior Vice President and General Manager for the business unit. The Oracle Health Sciences Global Business Unit will build on Oracle’s proven track record in the sector. Today, 20 of the 20 top pharmas and 14 of the 15 top U.S. hospitals run Oracle. The Oracle Health Sciences Global Business Unit will help health sciences organisations discover, develop and successfully market innovative products and services to prevent and cure disease, enhance quality of life and meet their shareholder and stakeholder expectations. Oracle today offers the sector’s most comprehensive suite of software applications for clinical development. These products can be deployed individually or together and include Oracle Clinical, Oracle Remote Data Capture, Oracle Thesaurus Management System, Oracle Adverse Event Reporting System, Oracle Life Sciences Data Hub and Oracle’s Siebel Clinical Trial Management System. Oracle’s application platform for health sciences helps companies bring together all the critical aspects of the clinical development, safety and pharmacovigilance processes into a single, open platform built on state-of-the-art technology. Oracle’s clinical applications provide a streamlined system for managing large volumes of patient data collected during clinical trials. They offer features for modeling any kind of clinical study, automatically storing components for reuse in a flexible global library. The company also offers Oracle Healthcare Transaction Base, which helps healthcare companies simultaneously improve patient care and control costs by providing a foundation for interoperability and integration of existing and new systems.